Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
LeMaitre Vascular, Inc. (LMAT) Stock-Based Compensation data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$249.60M |
|
$57.73M |
|
$71.06M |
|
$178.54M |
|
$181.69M |
|
$67.91M |
|
$7.27M |
|
$75.18M |
|
$75.18M |
|
$57.73M |
|
$57.73M |
|
$57.73M |
|
$57.73M |
|
$67.91M |
|
$67.91M |
|
22.64M |
|
22.93M |
|
$2.55 |
|
$2.52 |
|
| Balance Sheet Financials | |
$468.23M |
|
$27.00M |
|
$147.46M |
|
$615.69M |
|
$36.32M |
|
$168.65M |
|
$185.85M |
|
$222.17M |
|
$393.52M |
|
$294.48M |
|
$393.52M |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|